Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The induction of anti-tumor immune responses through immunogenic cell death (ICD) and subsequent immune infiltration is a therapeutic strategy that leverages the body’s own immune system to recognize, attack, and remember tumor cells. This process involves regulated forms of cell death in cancer cells that actively stimulate both innate and adaptive immunity, leading to durable anti-tumor effects. Key components include the release of DAMPs, activation of dendritic cells, and T cell-mediated cytotoxicity.
Induction of immunogenic cell death (ICD) leading to release of DAMPs, activation of antigen-presenting cells (APCs), and subsequent T cell-mediated anti-tumor immunity.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Induction of Anti-Tumor Immune Response Through Immunogenic Cell Death and Immune Infiltration (ICD-mediated Anti-Tumor Immunity).